Investigating the proliferative inhibition of HepG2 cells by exosome-like nanovesicles derived from Centella asiatica extract through metabolomics

Nano-particles demonstrating excellent Anticancer properties have gradually found application in Cancer therapy. However, their widespread use is impeded by their potential toxicity, high cost, and the complexity of the preparation process. In this study, we achieved exosome-like Centella asiatica-derived nanovesicles (ADNVs) through a straightforward juicing and high-speed centrifugation process. We employed transmission electron microscopy and nanoparticle flow cytometry to characterize the morphology, diameter, and stability of the ADNVs. We evaluated the in vitro Anticancer effects of ADNVs using Cell Counting Kit-8 and Apoptosis assays. Through Sequencing and bicinchoninic acid protein analysis, we discovered the abundant presence of proteins and MicroRNAs in ADNVs. These MicroRNAs can target various diseases such as Cancer and Infection. Furthermore, we demonstrated the effective internalization of ADNVs by HepG2 cells, resulting in an increase in Reactive Oxygen Species levels, mitochondrial damage, cell cycle arrest at the G1 phase, and Apoptosis. Finally, we analyzed changes in cellular metabolites post-treatment using cell metabolomics techniques. Our findings indicated that ADNVs primarily influence metabolic pathways such as amino acid metabolism and lipid biosynthesis, which are closely associated with HepG2 treatment. Our results demonstrate the potential utility of ADNVs as Anticancer agents.

Apoptosis; Cancer; Centella asiatica; Nanovesicles; UPLC-Q-Exactive Orbitrap MS.